Wall Street Advisor Initiates Coverage on Nutrition 21, Inc. (NXXI) with a Buy Recommendation.  

New York, June 2, 2005.  (BusinessWire) Wall Street Advisor LLC has initiated coverage of Nutrition 21, Inc. (NASDAQ: NXXI) with a Buy recommendation.   The report may be found at http://www.wallstreetadvisor.com/NXXI_Research.pdf

Nutrition 21, based in Purchase, NY, is a nutritional bioscience company and the maker of chromium-based supplements with health benefits substantiated by clinical research. The function of insulin, the body’s master metabolic hormone, is in part dependent on chromium that must be supplied through diet or supplementation. The Company markets  chromium picolinate, which is the most studied form of the essential mineral chromium. 

Wall Street Advisor is an independent equity research publishing and distribution company with AIMR-qualified professional analysts.  Please see full report for important disclaimers.  Full details of the company's policies and guidelines are posted on the website at http://www.wallstreetadvisor.com.

Contact:
  Wall Street Advisor LLC
  Christopher P. Moore, CFA
  chris@wallstreetadvisor.com
  (212) 593-1600